What is the current Price Target for the Disc Medicine stock?

The average Disc Medicine target price is $99.60. This is 88.96% higher than the current stock price. The highest price target is 150.43%, the lowest is 42.29%. 10 Analysts have issued a price target Disc Medicine 2026 .

How high will the Disc Medicine stock rise?

No reliable answer can be given as to how high the Disc Medicine stock will rise. The performance of stocks, including the Disc Medicine stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Disc Medicine stock today?

The performance of Disc Medicine stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Disc Medicine stock fall?

The decline in Disc Medicine stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Disc Medicine Forecast, price target & analysts

$52.71

3.64% yesterday

NYSE, Jun 12, 10:00 pm CET

ISIN

US2546041011

Symbol

IRON

Reports

Quarter | Annual

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Disc Medicine Target price 2025 - Analyst rating & recommendation

Disc Medicine Classifications & Recommendation:

Buy

100%

Disc Medicine Price Target

Target Price	$99.60
Price	$52.71
Potential	88.96% register free of charge
Number of Estimates	10

	10 Analysts have issued a price target Disc Medicine 2026 . The average Disc Medicine target price is $99.60. This is 88.96% register free of charge higher than the current stock price. The highest price target is $132.00 150.43% register free of charge , the lowest is $75.00 42.29% register free of charge .
	A rating was issued by 11 analysts: 11 Analysts recommend Disc Medicine to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Disc Medicine stock has an average upside potential 2026 of 88.96% register free of charge . Most analysts recommend the Disc Medicine stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-3.96	-4.51
	15.79%	13.89%
P/E		negative

7 Analysts have issued a Disc Medicine forecast for earnings per share. The average Disc Medicine EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-3.96	15.79%
2025	$-4.51 13.89% Unlock
2026	$-4.63 2.66% Unlock
2027	$-3.78 18.36% Unlock
2028	$0.14 103.70% Unlock
2029	$3.50 2,400.00% Unlock

Current	-15.10	25.09%
2025	-11.68 22.67% Unlock
2026	-11.38 2.57% Unlock
2027	-13.93 22.41% Unlock
2028	371.20 2,764.75% Unlock
2029	15.06 95.94% Unlock

Disc Medicine...

Current Disc Medicine Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Raymond James	Locked ➜ Locked	Locked	Jun 11 2025
BMO Capital	Locked ➜ Locked	Locked	May 12 2025
Cantor Fitzgerald	Locked ➜ Locked	Locked	Mar 18 2025
Scotiabank	Locked ➜ Locked	Locked	Mar 03 2025
Stifel	Locked ➜ Locked	Locked	Jan 24 2025
Scotiabank	Locked ➜ Locked	Locked	Jan 22 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jan 21 2025

Analyst Rating	Date
Locked Raymond James: Locked ➜ Locked	Jun 11 2025
Locked BMO Capital: Locked ➜ Locked	May 12 2025
Locked Cantor Fitzgerald: Locked ➜ Locked	Mar 18 2025
Locked Scotiabank: Locked ➜ Locked	Mar 03 2025
Locked Stifel: Locked ➜ Locked	Jan 24 2025
Locked Scotiabank: Locked ➜ Locked	Jan 22 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Jan 21 2025

Discover more stocks with a high price target

TUI 63.33%

Alibaba Group Holding Ltd 39.18%

NIO ADR 36.92%

BioNTech SE - ADR 32.72%

MongoDB 29.30%

Adidas 27.47%

Tencent Holdings Ltd. 25.42%

Deutsche Telekom 25.28%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now